Wānaka blood cancer patient, 36, to get cutting-edge CAR T-cell therapy in China - why experts want the therapy here
Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...
Researchers investigate rare side effect of blood cancer immunotherapy
Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...
Healio3h
VIDEO: CAR T-cell therapy shows promise in hard-to-treat mantle cell lymphoma
In this video, Stephen M. Ansell, MD, PhD professor of medicine, chair of the division of hematology, co-leader of the hematological malignancies program, and interim chair of the department of ...
Targeted Oncology5h
Strategies to Overcome CAR T Roadblocks in the Real-World Practice Setting
Panelists discuss how to address practical challenges in delivering chimeric antigen receptor (CAR) T cell therapy, including patient selection, bridging therapy, manufacturing delays, access barriers ...
Call for cancer treatment to be available on NHS
A father-of-two who is in remission from cancer is calling for the treatment which helped him to be made available on the NHS ...
Targeted Oncology20h
CAR T-Cells Demonstrate Efficacy, Tolerability in Early-Relapsed DLBCL
During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...